Wir verwenden Cookies für die optimale Funktion unserer Website. Wenn Sie weiter auf unserer Website surfen, erklären Sie sich mit unseren Regeln hinsichtlich des Setzens von Cookies einverstanden.

Hinweis

Die Seite befindet sich momentan im Aufbau, es sind noch nicht alle Publikationen vollständig gelistet.

Publikationsliste

Originalpublikationen

Originalpublikationen

Cerebral blood flow variability in fibromyalgia syndrome: Relationships with emotional, clinical and functional variables.PLOS ONE September 20, 2018
Montoro CI, Duschek S, Schuepbach D, Gandarillas M, Reyes del Paso GA


Cerebral blood flow modulations during preparatory attention and proactive inhibition.Biological Psychology. 137:65-72, 2018
Duschek S, Hoffmann A, Montoro C, Schuepbach D, Reyes del Paso GA, Ettinger U


Efficacy of Continuation/Maintenance Electroconvulsive Therapy (c/mECT) in the Treatment of Patients with Mood Disorders: A Retrospective Analysis
J ECT. 2018 Oct 20. doi: 10.1097/YCT.0000000000000547. [Epub ahead of print)
Hausmann A, Post T, Post F, Dehning J, Kemmler G, Grunze H


Testing a Clinical Staging Model for Bipolar Disorder using Longitudinal Life Chart Data
Bipolar Disord. 2018 Nov 17. doi: 10.1111/bdi.12727. [Epub ahead of print]
van der Markt A; Klumpers U, Draisma S, Dols A, Nolen WA, Post RM, Altshuler L, Frye MA, Grunze H, Keck P, McElroy SL,  Suppes T, Beekman TF, Kupka R


Revising DSM-5 criteria for the bipolar disorders: Phase I of the AREDOC project
Aust N Z J Psychiatry. 2018 Oct 31:4867418808382. doi: 10.1177/0004867418808382. [Epub ahead of print]
Parker G, Tavella G, Macqueen G, Michael Berk M, Grunze H , Deckersbach T, Dunner DL, Sajatovic M, Amsterdam JD , Ketter TA, Yatham LN, Kessing LV ,Bassett  D, Zimmerman M, Fountoulakis KN , Duffy A , Alda M, Calkin C, Sharma V, Anand A, Singh MK,  Hajek T, Boyce P, Frey BN , Castle DJ, Young AH, Vieta E, Rybakowski JK, Swartz HA, Schaffer A, Murray G, Bayes A, Lam RW, Bora E, Post RM, Ostacher MJ, Lafer B, Cleare AJ, Burdick KE, O’Donovan C, Ortiz A, Henry C, Kanba S, Rosenblat JD, Parikh SV, Bond DJ, Grunebaum MF, Frangou S, Goldberg JF, Orum M, Osser DN, Frye MA, McIntyre RS, Fagiolini A, Manicavasagar V, Carlson GA, Malhi GS


More Assortative Mating in Parents and Spouses of US Compared to European Patients with Bipolar Disorder: Implications for psychiatric illness in the offspring
Eur Arch Psychiatry Clin Neurosci. 2018 Aug 11. doi: 10.1007/s00406-018-0934-y. [Epub ahead of print] PMID: 30099616
Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Nolen WA


The use of (newer) antipsychotics in bipolar inpatients over a seventeen year observation period
Int Clin Psychopharmacol. 2018;33(6):297-303. PMID: 30095482
Dehning J, Grunze H, Walpoth-Niederwanger M, Kemmler G, Hausmann A


Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: An international consensus definition
Br J Psychiatry 2018, in press
Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare A, Di Florio A, Dietch D, Geddes J,  Goodwin GM, Grunze H, Hayes JF,  Jones I, Kasper S,  Macritchie K, McAllister-Williams H; Morriss R, Nayrouz S, Pappa S, Soares JC, Smith  DJ, Suppes T, Talbot P, Vieta E, Watson S, Yatham LN, Young AH, Stokes PRA


Multigenerational transmission of liability to psychiatric illness in offspring of parents with bipolar disorder
Bipolar Disord. 2018 Jun 21. doi: 10.1111/bdi.12668. [Epub ahead of print]
PMID:  29926532
Post R, Altshuler L, Kupka R, McElroy S,  Frye M,  Rowe M,  Grunze H, Suppes T, Keck P, Leverich G, Nolen W


Axis II Personality Disorders Are Linked to an Adverse Course of Bipolar Disorder
J. Nervous Mental Dis 2018; 206(6):469-472
PMID: 29781886
Post R, McElroy S, Kupka R, Suppes T, Hellemann G, Nolen W, Frye M, Keck P, Grunze H, Rowe M


Prevalence of axis II comorbidities in bipolar disorder: relationship to mood stateBipolar Disorders 2018;20:303–312PMID: 29369448Post R, Leverich G,  McElroy S, Kupka R, Suppes T, Altshuler L,  Nolen W, Frye M, Keck P, Grunze H, Hellemann G


Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional studyPsychopharmacology. 234:3-13. 2017Schreiner A, Caspi A, Bergmans P, Cherubin P, Keim S., Lara E, Pinchuk I, Schuepbach D, Suleman S, Hargarter L


The relationship between self-reported borderline personality features and prospective illness course in bipolar disorder
Int J Bipolar Disord. 2017;5(1):31
PMID: 28944443
Riemann G, Weisscher N, Post RM, Altshuler L, McElroy S, Frye MA, Keck PE Jr, Leverich GS, Suppes T, Grunze H, Nolen WA, Kupka RW


Lithiumtherapie bei eingeschränkter Nierenfunktion: Zwischen Skylla und Charybdis
Fortschr Neurol Psychiatr. 2017;85(5):288-291.
PMID: 28561179
Dehning J, Grunze H, Born C, Hausmann A


Bupropion Maintenance Treatment in Refractory Bipolar Depression: A Case Report
Clin Pract Epidemiol Ment Health. 2017;13:43-48
PMID: 28659991
Dehning J, Grunze H, Hausmann A.


Meta-Analysis of the Risk of Subsequent Mood Episodes in Bipolar Disorder
Psychother Psychosom. 2017;86(2):90-98
PMID: 28183076
Radua J, Grunze H, Amann BL


More childhood onset bipolar disorder in the United States than Canada or Europe: Implications for treatment and prevention
Neurosci Biobehav Rev. 2017;74 (Pt A):204-213
PMID: 28119069
Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE Jr, Leverich GS, Nolen WA


Illnesses in siblings of US patients with bipolar disorder relate to multigenerational family history and patients severity of illness
J Affect Disord. 2017;207:313-319
PMID: 27741468
Post R, Altshuler L,  Kupka R, McElroy S, Frye M, Rowe M, Grunze H, Suppes T, Keck P, Nolen W


Neuropsychological study of IQ scores in Offspring of parents with Bipolar I Disorder
Cognitive Neuropsychiatry 2017, 22(1), 17-27
PMID: 27855540
Camilleri N, Sharma A, Grunze H, Barron E, LeCouteur J, Close A, Rushton S, Kelly T, Ferrier IN,  LeCouteur A


Determinants of cerebral hemodynamics during the Trail Making Test in schizophrenia
Brain and Cognition. 109, 96-104. 2016
Schuepbach D, Egger ST, Boeker H, Duschek S, Vetter S, Seifritz E, Herpertz SC


Facial emotion labelling in unaffected offspring of adults with Bipolar I Disorder
J Affect Disord. 2016;208:198-204
PMID:27792963
Sharma A, Barron E, Le Couteur J, Close A, Rushton S, Grunze H, Kelly T, Ferrier N, Le Couteur A


Incidence, Characteristics and Course of Narrow Phenotype Paediatric Bipolar I Disorder in the British Isles
Acta Psychiatr Scand. 2016 , 134 (6), 522-532
PMID: 27744649
Sharma A, Neely J, Camilleri M, James A, Grunze H, Le Couteur A


Further Evidence of a Cohort Effect in Bipolar Disorder: More Early Onsets and Family History of Psychiatric Illness in More Recent Epochs
J Clin Psychiatry 2016;77 (8), 1043-1049
PMID: 27379705
Post RM, Kupka R, Keck PE Jr, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Leverich GS, Nolen W


Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder
Compr Psychiatry. 2016;66:146-156
PMID: 26995248
Post RM, Leverich GS, Kupka R, Keck PE Jr, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Nolen WA


Age at Onset of Bipolar Disorder Related to Parental and Grandparental Illness Burden
J Clin Psychiatry. 2016;77(10):e1309-e1315
PMID: 27631141
Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE Jr, Leverich GS, Nolen WA


Age of onset of bipolar disorder: Combined effect of childhood adversity and familial loading of psychiatric disorders
J Psychiatr Res. 2016;81:63-70
PMID: 27392070
Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE Jr, Leverich GS, Nolen WA


Depression in bipolar disorder: prevalence rate and clinical correlates during naturalistic
In the Stanley Bipolar Network American Journal of Psychiatry, 
Am J Psychiatry 2016;173(10):1015-1023
Miller S, Mintz,J, Hellermann G, McElroy S, Nolen W, Kupka R, Leverich G, Grunze H, Altshuler L, Post R. Mixed


More illness in offspring of bipolar patients from the U.S. compared to Europe
J Affect Disord. 2016 Feb;191:180-186
Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Leverich GS, Nolen WA


Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial
Lancet Psychiatry. 2016 Feb;3(2):117-2
McAllister-Williams RH, Anderson IM, Finkelmeyer A, Gallagher P, Grunze HC, Haddad PM, Hughes T, Lloyd AJ, Mamasoula C, McColl E, Pearce S, Siddiqi N, Sinha BN,  Steen N, Wainwright J, Winter FH, Ferrier IN, Watson S; ADD Study Team


A Bipolar II Cohort (ABC): the association of functional disability with gender and rapid cycling
J.Affect.Dis 2015;185:204-8
Scott J, Grunze H, Meyer T, Nendick J, Watkins H, Ferrier IN


Multigenerational Positive Family History of Psychiatric Disorders is Associated with a Poor Prognosis in Bipolar Disorder
The Journal of Neuropsychiatry and Clinical Neurosciences 2015; 27(4):304-10
Post  RM, Leverich GS, Kupka R, Keck P, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Nolen WA


Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: Experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I
Journal of Affective disorders 2015;174:70-82
Grunze H, Kotlik E, Costa R, Nunes T, Falcão A, Almeida L, Soares-da-Silva P.


Verbal, like Physical and Sexual, Abuse in Childhood Is Associated with an Earlier Onset and More Difficult Course of Bipolar Disorder
Bipolar Disord. 2015, 17(3):323-30
Post RM, Altshuler L, Kupka R, McElroy S, Frye MA, Rowe M,  Leverich GS,  Grunze H, Suppes T, Keck P, Nolen WA


Relationship of clinical course of illness variables to medical comorbidities in 900 adult outpatients with bipolar disorder
Comprehensive Psychiatry 2015, 56:21-8
Post RM, Altshuler L, Leverich GS, Frye MA, Suppes T, McElroy S, Keck P, Nolen WA, Kupka R, Grunze H, Rowe M


Randomised controlled trial of Antiglucocorticoid augmentation (metyrapone) of antiDepressants in Depression (ADD Study)
NIHR Journals Library; 2015 Jun
Ferrier IN, Anderson IM, Barnes J, Gallagher P, Grunze HCR, Haddad PM, House AO, Hughes T, Lloyd AJ, Mamasoula C, McColl E, Pearce S, Siddiqi N, Sinha B, Speed C, Steen N, Wainwright J, Watson S, Winter FH, McAllister-Williams R


The association of interoceptive awareness and alexithymia with neurotransmitter concentrations in insula and anterior cingulate
Social Cognitive and Affective Neuroscience. 9, 857-863. 2014
Ernst J, Böker H, Hättenschwiler J, Schuepbach D, Northoff G, Seifritz E, Grimm S


Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders
J. Affect. Dis. 2014; 168:439-51
Calabrese R, Fava M, Garibaldi G, Grunze H, Krystal A, Laughren T, Macfadden W, Marin R, Nierenberg A, Tohen M


Saving time and money: a validation of the self ratings on the prospective NIMH life-chart method (NIMH-LCM)
BMC Psychiatry 2014; 14:130 (7 May 2014)
Born C, Amann BL, Grunze H, Post RM, Schärer L


More Pernicious Course of Bipolar Disorder in the United States than in Many European Countries: Implications for policy and treatment
J.Affect.Dis 2014;160:27-33
Post RM, Altshuler L, Kupka R, McElroy S, Frye MA, Rowe M,  Leverich GS,  Grunze H, Suppes T, Keck P, Nolen WA


Phenomenology of Manic Episodes According to the Presence or Absence of Depressive Features as Defined in DSM-5: Results from the IMPACT Self-reported Online Survey
J.Affect.Dis 2014; 156, 206-213
Vieta E, Grunze H, Azorin JM, Fagiolini A


Increased parental history of bipolar disorder in the United States: association with early age of onset
Acta Psychiat Scand 2014;129(5):375-382
Post RM, Leverich GS, Kupka R, Keck P, McElroy S, Altshuler L, Frye MA, Luckenbaugh DA, Rowe M, Grunze H, Suppes T, Nolen WA


Polypharmacy and bipolar disorder: what's personality got to do with it? Int J Neuropsychopharmacol.
2014 Jul;17(7):1053-61
Sachs GS, Peters AT, Sylvia GS, Grunze H


Family Environment of Bipolar Families: A UK study
J Affect.Disord.,2014; 152-154:522-525
Barron E, Sharma A, Le Couteur J, Rushton S, Close A, Kelly T, Grunze H, Ferrier IN, Le Couteur A


Ziprasidone - Not Haloperidol - Induces more de-novo Neurogenesis of Adult Neural Stem Cells Derived from Murine Hippocampus
Pharmacopsychiatry. 2013; 46(1):10-5Pharmacopsychiatry. 2013; 46(1):10-5
Benninghoff J, Grunze H, Schindler C, Genius J, Schlösser RJ, van der Ven A, Dehning S, Wiltfang J, Möller HJ, Rujescu D. 


Study protocol for the randomised controlled trial: Antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)
BMC.Psychiatry. 2013;13:205
McAllister-Williams RH, Smith E, Anderson IM, Barnes J, Gallagher P, Grunze HC, Haddad P,  House AO, Hughes T, Lloyd AJ , McColl EM, Pearce SH, Siddiqi N, Sinha B, Speed C, Steen IN, Wainright J,  Watson S, Winter FH, Ferrier IN


Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study
BMC Psychiatry,2013; 13:193
Krämer S, Minarzyk A, Eppendorfer S, Henneges C, Hundemer HP, Wilhelm St, Grunze H


More stressors prior to and during the course of bipolar illness in patients from the United States compared with the Netherlands and Germany
Psychiatry Res, 2013; 210,880-886
Post RM, Altshuler L, Leverich G, Nolen W, Kupka R, Grunze H, Frye M, Suppes T, McElroy S, Keck P, Rowe M


The potential role of Marginal Structural Models (MSMs) in testing the effectiveness of antidepressants in the treatment of patients with major depression in everyday clinical practice
World J Biol Psychiatry. 2013; 14, 386-395
Severus E, Lipkovich I, Seemüller F, Obermeier M, Grunze H, Bernhard B, Dittmann S, Riedel M, Möller HJ


Role of childhood adversity in the development of medical co-morbidities associated with bipolar disorder
J Affect Disord. 2013; 147:288-294
Post RM, Altshuler LL, Leverich GS, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Nolen WA, Kupka RW, Grunze H, Rowe M


Interpreting magnetic resonance imaging findings in bipolar disorder
CNS Neurosci Ther. 2012; 18(3):201-7
Cousins DA, Grunze H.


Cerebral blood flow dynamics during pain processing in patients with fibromyalgia syndrome
Psychosomatic Medicine, 74, 802-809, 2012
Duschek S, Mannhart T, Winkelmann A, Merzoug K, Werner NS, Schuepbach D, Montoya P


Sustained cognitive impairments after clinical recovery of severe depression
Journal of Nervous and Mental Disease, 200, 773-776. 2012
Boeker H, Schulze J, Richter A, Nikisch G, Schuepbach D, Grimm S


Gender and rapid alterations of hemispheric dominance
Neuropsychobiology, 66, 149-157. 2012
Schuepbach D, Skotchko T, Duschek S, Theodoridou A, Grimm S, Böker H, Seifritz E


Treatment patterns in inpatients with bipolar disorder at a psychiatric university hospital over a 9-year period: focus on mood stabilizers
Int Clin Psychopharmacol. 2012; 27(5):256-6
Walpoth-Niederwanger M, Kemmler G, Grunze H, Weiss U, Hörtnagl C, Strauss R, Blasko I, Hausmann A


Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients
J Clin Psychiatry. 2012; 73(7):924-30
Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Nolen WA, Rowe M, Kupka RW, Grunze H, Goodwin FK


Impaired functioning in euthymic patients with bipolar disorder--HSV-1 as a predictor
Prog Neuropsychopharmacol Biol Psychiatry. 2012; 10:36(1):110-6
Gerber SI, Krienke UJ, Biedermann NC, Grunze H, Yolken RH, Dittmann S, Langosch JM.


Reduced negative BOLD responses in the default-mode network and increased self-focus in depression
The World Journal of Biological Psychiatry, 12, 627-637. 2011
Grimm S, Ernst J, Boesiger P, Schuepbach D, Boeker H, Northoff G


Self-regulation of cerebral blood flow by means of transcranial Doppler sonography biofeedback
Annals of Behavioral Medicine 41, 235-242. 2011
Duschek S, Schuepbach D, Doll A, Werner N & Reyes del Paso GA


Gender characteristics of cerebral hemodynamics during complex cognitive functioning
Brain and Cognition 76, 123-130. 2011
Misteli M, Duschek S, Richter A, Grimm S, Rezk M, Kraehenmann R, Boeker H, Seifritz E, Schuepbach D


Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany
Int Clin Psychopharmacol. 2011; 26(2):96-106
Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Nolen WA, Kupka R, Grunze H, Walden J, Rowe M


2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery
Eur Neuropsychopharmacol. 2011; 21(4):287-9
Haro JM, Reed C, Gonzalez-Pinto A, Novick D, Bertsch J, Vieta E; EMBLEM Advisory Board


Reliabilitat und Ubereinstimmungsvaliditat der deutschen Version der Young Mania Rating Scale (YMRS-D)
Neuropsychiatr. 2011; 25(1):16-25
Mühlbacher M, Egger C, Kaplan P, Simhandl C, Grunze H, Geretsegger C, Whitworth A, Stuppäck C


Interactions between systemic hemodynamics and cerebral blood flow during attentional processing
Psychophysiology 47, 1159–1166. 2010
Duschek S, Heiss H, Schmidt MF, Werner NS, Schuepbach D


Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder
J Clin Psychiatry. 2010; 71(9):1176-86
Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE Jr, McElroy SL, Leverich GS, Luckenbaugh DA, Rowe M, Pizzarello S, Kupka RW, Grunze H, Nolen WA


Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood
J Clin Psychiatry. 2010; 71(7):864-72
Post RM, Leverich GS, Kupka RW, Keck PE Jr, McElroy SL, Altshuler LL, Frye MA, Luckenbaugh DA, Rowe M, Grunze H, Suppes T, Nolen WA


Work impairment in bipolar disorder patients--results from a two-year observational study (EMBLEM)
Eur Psychiatry. 2010; 25(6):338-44
Reed C, Götz I, Vieta E, Bassi M, Haro JM; EMBLEM Advisory Board


Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network
Am J Psychiatry. 2010; 167(6):708-15
Altshuler LL, Kupka RW, Hellemann G, Frye MA, Sugar CA, McElroy SL, Nolen WA, Grunze H, Leverich GS, Keck PE, Zermeno M, Post RM, Suppes T


What works for delirious catatonic mania?
BMJ Case Rep. 2010; 15:2010
Vasudev K, Grunze H


Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cells
Neuropsychopharmacology. 2010; 35(4): 893-903
Benninghoff J, Gritti A, Rizzi M, Lamorte G, Schlösser RJ, Schmitt A, Robel S, Genius J, Mössner R, Riederer P, Manji HK, Grunze H, Rujescu D, Möller HJ, Lesch KP, Vescovi AL


Rapid cerebral hemodynamic modulation during set shifting: evidence of time-locked associations with cognitive control in females
Brain and Cognition 71, 313-319. 2009
Schuepbach D, Huizinga M, Duschek S, Grimm S, Boeker H, Hell D


Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology.
Acta Psychiatr Scand. 2009; 120(6):474-80
Born C, Seitz NN, Grunze H, Vieta E, Dittmann S, Seemüller F, Amann B.


Increased self-focus in major depressive disorder is related to neural abnormalities in subcortical-cortical midline structures
Human Brain Mapping 30, 2617-2627. 2009
Grimm S, Ernst J, Boesiger P, Schuepbach D, Hell D, Boeker H, Northoff G


Segregated neural representation of psychological and somatic-vegetative symptoms in severe major depression
Neuroscience Letters 456, 49-53. 2009
Heinzel A, Grimm S, Beck J, Schuepbach D, Hell D, Boesiger P, Boeker H, Northoff G


Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.J Clin Psychiatry. 2009; 70(4):450-7
Altshuler LL, Post RM, Hellemann G, Leverich GS, Nolen WA, Frye MA, Keck PE Jr, Kupka RW, Grunze H, McElroy SL, Sugar CA, Suppes T.


Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM)
Affect Disord. 2009; 118(1-3):118-23
Vieta E, Angst J, Reed C, Bertsch J, Haro JM; EMBLEM advisory board


Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis
Nerv Ment Dis. 2009; 197(1):35-40
van Rossum I, Boomsma M, Tenback D, Reed C, van Os J; EMBLEM Advisory Board


Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study
Nord J Psychiatry. 2009; 63(4):285-91
Larsen JK, Porsdal V, Aarre TF, Koponen HJ, Aarnio J, Kleivenes OK; Emblem Advisory Board


Bipolar disorder in the elderly; different effects of age and of age of onset
J Affect Disord. 2009; 116(3):176-83
Oostervink F, Boomsma MM, Nolen WA; EMBLEM Advisory Board.


Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression
Am J Psychiatry. 2009; 166(2):164-72
Frye MA, Helleman G, McElroy SL, Altshuler LL, Black DO, Keck PE Jr, Nolen WA, Kupka R, Leverich GS, Grunze H, Mintz J, Post RM, Suppes T


Altered negative BOLD responses in the default-mode network during emotion processing in depressed subjects
Neuropsychopharmacology 34, 932-943. 2009
Grimm S, Boesiger P, Beck J, Schuepbach D, Bermpohl F, Walter M, Ernst J, Hell D, Boeker H, Northoff G


Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study
Pharmacopsychiatry. 2009; 42(4):145-52
Novick D, Gonzalez-Pinto A, Haro JM, Bertsch J, Reed C, Perrin E, Tohen M; EMBLEM Advisory Board


Lamotrigine in bipolar disorder: results of a mirror-image evaluation using the NIMH Lifechart-Methodology
J Affect Disord. 2009; 115(1-2):241-5
Born C, Bernhard B, Dittmann S, Seemüller F, Grunze H


The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study
J Clin Psychiatry. 2008; 69(6):899-906
Dittmann S, Seemüller F, Grunze HC, Schwarz MJ, Zach J, Fast K, Born C, Dargel S, Engel RR, Bernhard B, Möller HJ, Riedel M, Severus WE


Use of remote centralized raters via live 2-way video in a multicenter clinical trial for schizophrenia
J Clin Psychopharmacol. 2008; 28:691-693
Grunze HC, Höschl C, Montgomery SA, Sartorius N, Vieta E. Response to Shen J, Kobak K, Zhao Y, et al


Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate
J Clin Psychopharmacol. 2008; 28(5):555-60
Langosch JM, Drieling T, Biedermann NC, Born C, Sasse J, Bauer H, Walden J, Bauer M, Grunze H


Geschwindigkeit des Depressionsbeginns: Ein Unterscheidungsmerkmal hinsichtlich uni- versus bipolarer affektiver Storungen
Neuropsychiatr. 2008; 22(2):92-9
Hegerl U, Bottner AC, Mergl R, Holtschmidt-Täschner B, Seemüller F, Scheunemann W, Schütze M, Grunze H, Henkel V, Angst J, Born C


Incidence of childhood-onset bipolar illness in the USA and Europe
Br J Psychiatry. 2008; 192(2):150-1
Post RM, Luckenbaugh DA, Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Nolen WA, Kupka R, Grunze H, Walden J


Onset of depressive episodes is faster in patients with bipolar versus unipolar depressive disorder: evidence from a retrospective comparative study
J Clin Psychiatry. 2008; 69(7):1075-80
Hegerl U, Bottner AC, Holtschmidt-Täschner B, Born C, Seemüller F, Scheunemann W, Schütze M, Grunze H, Henkel V, Mergl R, Angst J


Are bipolar mood symptoms affected by the phase of the menstrual cycle?
J Womens Health (Larchmt). 2008; 17(3):473-8
Shivakumar G, Bernstein IH, Suppes T; Stanley Foundation Bipolar Network, Keck PE, McElroy SL, Altshuler LL, Frye MA, Nolen WA, Kupka RW, Grunze H, Leverich GS, Mintz J, Post RM


Cognitive functioning in euthymic bipolar I and bipolar II patients
Bipolar Disord. 2008; 10(8):877-87 
Dittmann S, Hennig-Fast K, Gerber S, Seemüller F, Riedel M, Emanuel Severus W, Langosch J, Engel RR, Möller HJ, Grunze HC


A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode
Int Clin Psychopharmacol. 2008; 23(5):254-62
Bowden C, Göğüş A, Grunze H, Häggström L, Rybakowski J


Stability and treatment outcome of distinct classes of mania
Eur Psychiatry. 2008; 23(5):360-7
van Rossum I, Haro JM, Tenback D, Boomsma M, Götz I, Vieta E, van Os J; EMBLEM Advisory Board


Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study
J Affect Disord. 2008; 106(1-2):63-72
Vieta E, Panicali F, Götz I, Reed C, Comes M, Tohen M; EMBLEM Advisory Board


Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism
Schizophr Res. 2007; 97(1-3):254-6
Braun I, Genius J, Grunze H, Bender A, Möller HJ, Rujescu D.


Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network
Int Clin Psychopharmacol. 2007; 22(6):376-81
Suppes T, Kelly DI, Keck PE Jr, McElroy SL, Altshuler LL, Mintz J, Frye MA, Nolen WA, Luckenbaugh DA, Post RM, Leverich GS, Kupka RW, Grunze H


Risperidone monotherapy in manic inpatients: an open label, multicentre trial
World J Biol Psychiatry. 2007; 8(4):256-61
Forsthoff A, Grunze H, Seemüller F, Stampfer R, Dittmann S, Amann B, Schmidt F, Schäfer M, Hermle L, Walden J, Schreiner A


Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder
Bipolar Disord. 2007; 9(5):531-5
Kupka RW, Altshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, Frye MA, Keck PE Jr, McElroy SL, Grunze H, Post RM


A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression
Am J Psychiatry. 2007; 164(8):1242-9
Frye MA, Grunze H, Suppes T, McElroy SL, Keck PE Jr, Walden J, Leverich GS, Altshuler LL, Nakelsky S, Hwang S, Mintz J, Post RM


The poor prognosis of childhood-onset bipolar disorder
J Pediatr. 2007; 150(5):485-90
Leverich GS, Post RM, Keck PE Jr, Altshuler LL, Frye MA, Kupka RW, Nolen WA, Suppes T, McElroy SL, Grunze H, Denicoff K, Moravec MK, Luckenbaugh D


Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study
Acta Psychiatr Scand. 2007; 115(5):360-5
Nolen WA, Kupka RW, Hellemann G, Frye MA, Altshuler LL, Leverich GS, Suppes T, Keck PE Jr, McElroy S, Grunze H, Mintz J, Post RM


Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and ist impact on psychosocial functioning: preliminary results
Bipolar Disord. 2007; 9(1-2):63-70
Dittmann S, Seemüller F, Schwarz MJ, Kleindienst N, Stampfer R, Zach J, Born C, Bernhard B, Fast K, Grunze H, Engel RR, Severus E


Developing core sets for persons with bipolar disorder based on the International Classification of Functioning, Disability and Health
Bipolar Disord. 2007; 9(1-2):16-24
Vieta E, Cieza A, Stucki G, Chatterji S, Nieto M, Sánchez-Moreno J, Jäger J, Grunze H, Ayuso-Mateos JL


Alcoholism and anxiety in bipolar illness: differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism
J Affect Disord. 2007; 101(1-3):211-7
Levander E, Frye MA, McElroy S, Suppes T, Grunze H, Nolen WA, Kupka R, Keck PE Jr, Leverich GS, Altshuler LL, Hwang S, Mintz J, Post RM


A 2-year, open-label pilot study of adjunctive chromium in patients with treatment-resistant rapid-cycling bipolar disorder
J Clin Psychopharmacol. 2007; 27(1):104-6
Amann BL, Mergl R, Vieta E, Born C, Hermisson I, Seemüller F, Dittmann S, Grunze H


Influence of sub-syndromal symptoms after remission from manic or mixed episodes
Br J Psychiatry. 2006; 189:515-9
Tohen M, Bowden CL, Calabrese JR, Lin D, Forrester TD, Sachs GS, Koukopoulos A, Yatham L, Grunze H


Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study
J Clin Psychiatry. 2006; 67(10):1551-60
Altshuler LL, Post RM, Black DO, Keck PE Jr, Nolen WA, Frye MA, Suppes T, Grunze H, Kupka RW, Leverich GS, McElroy SL, Walden J, Mintz J


An exploratory open trial on safety and efficacy of the anticonvulsant retigabine in acute manic patients. J Clin Psychopharmacol
2006; 26(5):534-6
Amann B, Sterr A, Vieta E, Stampfer R, Walden J, Grunze H


Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry
2006; 189:124-31. Erratum in: Br J Psychiatry. 2006; 189:569
Post RM, Altshuler LL, Leverich GS, Frye MA, Nolen WA, Kupka RW, Suppes T, McElroy S, Keck PE, Denicoff KD, Grunze H, Walden J, Kitchen CM, Mintz J


Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder
Biol Psychiatry. 2006; 60(9):1020-2
Keck PE Jr, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM


Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants
Am J Psychiatry. 2006; 163(2):313-5
Altshuler LL, Suppes T, Black DO, Nolen WA, Leverich G, Keck PE Jr, Frye MA, Kupka R, McElroy SL, Grunze H, Kitchen CM, Post R


A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities
Biol Psychiatry. 2006; 15:59(8):721-9
Rujescu D, Bender A, Keck M, Hartmann AM, Ohl F, Räder H, Giegling I, Genius J, McCarley RW, Möller HJ, Grunze H.


Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers
Am J Psychiatry. 2006; 163(2):232-9
Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM


Tourette's symptoms provoked by lamotrigine in a bipolar patient
Am J Psychiatry. 2006; 163(1):159
Seemüller F, Dehning S, Grunze H, Müller N


Impact of cognitive-psychoeducational interventions in bipolar patients and their relatives
Eur Psychiatry. 2006; 21(2):81-6
Bernhard B, Schaub A, Kümmler P, Dittmann S, Severus E, Seemüller F, Born C, Forsthoff A, Licht RW, Grunze H


Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study
Acta Psychiatr Scand. 2006;113(2):112-20
Haro JM, van Os J, Vieta E, Reed C, Lorenzo M, Goetz I; EMBLEM Advisory Board


Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon
Arch Gen Psychiatry. 2005; 62(10):1089-96
Suppes T, Mintz J, McElroy SL, Altshuler LL, Kupka RW, Frye MA, Keck PE Jr, Nolen WA, Leverich GS, Grunze H, Rush AJ, Post RM


Zotepine loading in acute and severely manic patients: a pilot study
Bipolar Disord. 2005; 7(5):471-6
Amann B, Sterr A, Mergl R, Dittmann S, Seemüller F, Dobmeier M, Orth M, Schäfer M, Grunze H


Levetiracetam add-on treatment for bipolar patients suffering from subsyndromal symptoms: preliminary data of an open 6-month longitudinal study
Eur Neuropsychopharmacol. 2005; 15 suppl 3:416
Bernhard B, Born C, Seemüller F, Grunze H


Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial
Am J Psychiatry. 2005; 162(7):1281-90
Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL


Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients
Am J Psychiatry. 2005; 162(7):1273-80
Kupka RW, Luckenbaugh DA, Post RM, Suppes T, Altshuler LL, Keck PE Jr, Frye MA, Denicoff KD, Grunze H, Leverich GS, McElroy SL, Walden J, Nolen WA


Walden J, Post R, Mintz J. Reproductive function and risk for PCOS in women treated for bipolar disorder
Bipolar Disord. 2005; 7(3):246-59
Rasgon NL, Altshuler LL, Fairbanks L, Elman S, Bitran J, Labarca R, Saad M, Kupka R, Nolen WA, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Leverich G, Grunze H, Walden J, Post R, Mintz J


Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial
J Clin Psychiatry. 2005; 66(5):617-24
McElroy SL, Suppes T, Keck PE Jr, Black D, Frye MA, Altshuler LL, Nolen WA, Kupka RW, Leverich GS, Walden J, Grunze H, Post RM


An overview of the findings of the Stanley Foundation Bipolar Network (SFBN) and Bipolar Collaborative Network (BCN): A focus on anticonvulsants
Aspects of Affect. 2005; 1:8-17
Post R, and the SFBN Principal Investigators


The anticonvulsant zonisamide in bipolar illness: Clinical response and weight loss
Aspects of Affect. 2005; 1:53-56
Leverich G, McElroy S, Altshuler L, Frye M, Grunze H, Keck PE, Kupka R, Nolen W, Suppes T, Walden J, Post R


Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder
J Clin Psychiatry. 2005; 66(3):370-4
ost RM, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Leverich GS, Kupka R, Nolen WA, Luckenbaugh DA, Walden J, Grunze H


A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder
J Clin Psychiatry. 2005; 66(1):111-21
Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vågerö M, Svensson K


Serum levels of substance P and response to antidepressant pharmacotherapy
Pharmacopsychiatry. 2004; 37(5):238-9
Lieb K, Walden J, Grunze H, Fiebich BL, Berger M, Normann C.


Risperidon: akute Manie bei multiplen somatischen Vorerkrankungen
psychoneuro 2004; 30(1): 25-27
Forsthoff A, Pajonk FG , Grunze H


Paroxetine in major depression: correlating plasma concentrations and clinical response
Pharmacopsychiatry. 2004; 37(3):123-6
Normann C, Hörn M, Hummel B, Grunze H, Walden J


The range of Hopy/manic Severities on Antidepressants: A randomised, dopuble blind comparison of Bupropion, Sertraline and Venlafaxine using daily NIMH-LCM ratings
Acta Psychiatr. Scand. 2004; Suppl 110:39
Leverich G, Altshuler L, Frye M, Suppes T, McElroy S, Keck P, Kupka R, Nolen W, Grunze H, Mertinez M, Post R


Use of quetiapine in bipolar disorder: a case series with prospective evaluation
Int Clin Psychopharmacol. 2004; 19(3):173-4
Suppes T, McElroy SL, Keck PE, Altshuler L, Frye MA, Grunze H, Leverich GS, Nolen WA, Chisholm K, Dennehy EB, Post RM


A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder
J Clin Psychiatry. 2004; 65(3):432-41
Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R


Association of cognitive deficits with elevated homocysteine plasma levels in euthymic bipolar patienst: preliminary results
Acta Psychiatr. Scand. 2004; Suppl 110(423):19
Dittmann S, Seemüller F,Schwarz M, Engel R, Grunze H, Severus WE


EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects.
Hum Psychopharmacol. 2003; 18(8):641-6
Amann BL, Pogarell O, Mergl R, Juckel G, Grunze H, Mulert C, Hegerl U


Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design
J Clin Psychiatry. 2003; 64(7):781-4
Grunze H, Langosch J, Born C, Schaub G, Walden J


Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.
Am J Psychiatry. 2003; 160(7):1252-62
Altshuler L, Suppes T, Black D, Nolen WA, Keck PE Jr, Frye MA, McElroy S, Kupka R, Grunze H, Walden J, Leverich G, Denicoff K, Luckenbaugh D, Post R


Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network
J Clin Psychiatry. 2003; 64(5):506-15
Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE Jr, McElroy SL, Denicoff KD, Obrocea G, Nolen WA, Kupka R, Walden J, Grunze H, Perez S, Luckenbaugh DA, Post RM


Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups
Hepatology. 2003; 37(2):443-51
Schäfer M, Schmidt F, Folwaczny C, Lorenz R, Martin G, Schindlbeck N, Heldwein W, Soyka M, Grunze H, König A, Löschke K


Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder
Am J Psychiatry. 2003; 160(5):883-9
Frye MA, Altshuler LL, McElroy SL, Suppes T, Keck PE, Denicoff K, Nolen WA, Kupka R, Leverich GS, Pollio C, Grunze H, Walden J, Post RM


Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol
Neuropsychobiology. 2002; 46 Suppl 1:31-5
Grunze H, Marcuse A, Schärer LO, Born C, Walden J


The Stanley Foundation Bipolar Network: results of the naturalistic follow-up study after 2.5 years of follow-up in the German centres
Neuropsychobiology. 2002; 46 Suppl 1:2-9
Dittmann S, Biedermann NC, Grunze H, Hummel B, Schärer LO, Kleindienst N, Forsthoff A, Matzner N, Walser S, Walden J


Life charts on a palmtop computer: first results of a feasibility study with an electronic diary for bipolar patients
Bipolar Disord. 2002; 4 Suppl 1:107-8
Schärer LO, Hartweg V, Valerius G, Graf M, Hörn M, Biedermann C, Walser S, Bönsch A, Dittmann S, Forsthoff A, Hummel B, Grunze H, Walden J


Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design
Bipolar Disord. 2002; 4(6):412-7
Hummel B, Walden J, Stampfer R, Dittmann S, Amann B, Sterr A, Schäfer M, Frye MA, Grunze H.


Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study.
J Clin Psychiatry2002; 63(4):337-44
Normann C, Hummel B, Schärer LO, Hörn M, Grunze H, Walden J


Correlates of overweight and obesity in 644 patients with bipolar disorder
J Clin Psychiatry. 2002; 63(3):207-13
McElroy SL, Frye MA, Suppes T, Dhavale D, Keck PE Jr, Leverich GS, Altshuler L, Denicoff KD, Nolen WA, Kupka R, Grunze H, Walden J, Post RM


Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective  disorders. A case series. Neuropsychobiology
2002; 45 Suppl 1:37-42
Hummel B, Dittmann S, Forsthoff A, Matzner N, Amann B, Grunze H


Levetiracetam and ethusuximide in the treatment of acute mania in an open study with an on-off-on design
Bipolar Disord. 2002; 4 Suppl 1:114
Walden J, Langosch J, Born C, Schaub G, Grunze H


Interferon alpha (INFalpha) and psychiatric syndromes: a review. Prog. Neuropsychopharmacol
Biol. Psychiatry. 2002; 26(4):731-746
Schäfer M, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Schmidt F, Grunze H, Lieb K


Chromium as antidepressant and mood stabilizer in refractorycycling patients: a case report
Bipolar Disorders. 2002; 4 Suppl 1:123
Amann B, Forsthoff A, Matzner N, Dargel S, Grunze H


Pyrones exert effects on neuronal transmission and transmembraneous cation currents similar to established mood stabilizers--a review
Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25(8):1555-70
Grunze H, Langosch J, Schirrmacher K, Bingmann D, Von Wegerer J, Walden J. Kava


Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression?
J Affect Disord. 2001; 67(1-3):141-6
Möller HJ, Bottlender R, Grunze H, Strauss A, Wittmann J


Interferon-alpha-assoziierte Agranulozytose wahrend Clozapin-Behandlung.
Kasuistik und Wissensstand Nervenarzt. 2001; 72(11):872-5
Schäfer M, Schmidt F, Grunze H, Laakmann G, Löschke K


Nichtletale Wirkung hochtoxischer Amitriptylin-Spiegel nach Suizidversuch. Ein Fallbericht
Nervenarzt. 2001; 72(1):52-5
Amann B, Grunze H, Hoffmann J, Schäfer M, Kuss HJ


Lamotrogine as adjunct to paroxetine in the treatment of depression – evaluation of efficacy, safety and drug interaction
World J Biol Psychiatry. 2001; 2 suppl 1:183
Normann C, Schärer LO, Hummel B, Grunze H, Walden J


An Update on the Stanley Foundation Bipolar Network (SFBN)
Bipolar Disord. 2001; 3 suppl 1:13-14
Post RM, Altshuler LL, Frye MA, Suppes T, Rush J, Keck PE, McElroy S, Denicoff KD, Leverich GS, Kupka RW, Nolen WA, Grunze H, Walden J


Central pontine myelinolysis in a patient with anorexia nervosa
Int J Eat Disord. 2001; 30(4):462-6
Amann B, Schäfer M, Sterr A, Arnold S, Grunze H


Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design
J Clin Psychiatry. 2001; 62(6):464-8
Grunze HC, Normann C, Langosch J, Schäfer M, Amann B, Sterr A, Schlösser S, Kleindienst N, Walden J.


The Stanley Foundation Bipolar Network. I. Rationale and methods
Br J Psychiatry Suppl. 2001; 41:169-76. Review
Post RM, Nolen WA, Kupka RW, Denicoff KD, Leverich GS, Keck PE Jr, McElroy SL, Rush AJ, Suppes T, Altshuler LL, Frye MA, Grunze H, Walden J


Short-term and long-term effects of N-methyl-D-aspartate receptor hypofunction
Arch Gen Psychiatry. 2000; 57(12):1180-1
Greene R, Bergeron R, McCarley R, Coyle JT, Grunze H.


Wirksamkeit, Verträglichkeit und Praktikabilität von Valproat-Miniretardtabletten bei bipolaren affektiven Störungen
Fortschr Neurol Psychiatr. 2000; 68(11):496-502
Grunze H, Amann B, Schäfer M, Sterr A, Schärer L, Wild E, Walden J


An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization
Bipolar Disord. 2000; 2(4):336-9
Walden J, Schärer L, Schlösser S, Grunze H


Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis
Neuropsychobiology. 2000; 42 Suppl 1:43-5
Schäfer M, Schmidt F, Amann B, Schlösser S, Löschke K, Grunze H


Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study
J Clin Psychopharmacol. 2000;20(2):195-203
Müller-Oerlinghausen B, Retzow A, Henn FA, Giedke H, Walden J., European Valproate Mania Study Group


Bupropion-induced isolated impairment of sensory trigeminal nerve function
Int Clin Psychopharmacol. 2000; 15(2):115-6
Amann B, Hummel B, Rall-Autenrieth H, Walden J, Grunze H


Psychopathological and auditory evoked potential correlates of ketamine psychosis--a single case report
Schizophr Res. 2000; 21:41(2):386-8
Grunze H, Gallinat J, Haag C, Hegerl U


Psychopathological changes preceding motor symptoms in Huntington's disease: a report on four cases
World J Biol Psychiatry. 2000; 1(1):55-8
Amann B, Sterr A, Thoma H, Messer T, Kapfhammer HP, Grunze H


Modulation of neural cell membrane conductance by the herbal anxiolytic and antiepileptic drug aswal
Neuropsychobiology. 2000; 42 Suppl 1:28-32
Grunze H, Langosch J, von Löwenich C, Walden J.


New insights into the mechanisms and sites of action of lamotrigine
Neuropsychobiology. 2000; 42 Suppl 1:26-7
Langosch JM, Zhou XY, Grunze H, Walden J.


Effects of lamotrigine on field potentials and long-term potentiation in guinea pig hippocampal slices
Epilepsia. 2000; 41(9):1102-6
Langosch JM, Zhou XY, Frick A, Grunze H, Walden J.


Neurotoxicity of NMDA antagonists: a glutamatergic theory of schizophrenia based on selective impairment of local inhibitory feedback circuits
Dialogues Clin Neurosci. 2000; 2(3):287-98
Grunze H, Bender A, Wendhof S, Schäfer M, Rujescu D.


Dysregulation of ion fluxes in bipolar affective disorder
Acta Neuropsychiatrica. 2000; 12:81-85
Grunze H, Langosch J, Norman C, Rujescu D, Amann B, Walden J. 


Treatment of acute mania with topiramate
Am J Psychiatry. 1999; 156(12):2014
Normann C, Langosch J, Schärer LO, Grunze H, Walden J


Tiagabine appears not to be efficacious in the treatment of acute mania
J Clin Psychiatry. 1999; 60(11):759-62
Grunze H, Erfurth A, Marcuse A, Amann B, Normann C, Walden J


Trimipramine fails to exert antimanic efficacy: a case of the discrepancy between in vitro rationale and clinical efficacy
Clin Neuropharmacol. 1999; 22(5):298-300
Grunze H, Erfurth A, Walden J


Intravenous valproate loading in acutely manic and depressed bipolar I patients
J Clin Psychopharmacol. 1999; 19(4):303-9
Grunze H, Erfurth A, Amann B, Giupponi G, Kammerer C, Walden J


Treatment of tardive akathisia with clonidine: a case report. Int J Neuropsychopharmacol
1999; 2(2):151-153
Amann B, Erfurth A, Grunze H


Elektrokonvulsionstherapie in der Behandlung der schweren Manie
Kasuistik und Wissensstand. 1999; 70(7):662-7
Grunze H, Erfurth A, Schäfer M, Amann B, Meyendorf R


Gabapentin in der Behandlung der akuten Manie
1999; 67(6):256-60
Grunze H, Erfurth A, Amann B, Normann C, Walden J


Schwere therapieresistente Depression als Erstmanifestation eines Morbus Parkinson
Psychiatr Prax. 1999; 26(1):45-7
Amann B, Erfurth A, Back T, Grunze H


An open label study of gabapentin in the treatment of acute mania
J Psychiatr Res. 1998; 32(5):261-4
Erfurth A, Kammerer C, Grunze H, Normann C, Walden J


New perspectives in the treatment of acute mania: a single case report
Prog Neuropsychopharmacol Biol Psychiatry. 1998; 22(6):1053-9
Erfurth A, Grunze H


Lamotrigine in the treatment of schizoaffective disorder.
Neuropsychobiology. 1998; 38(3):204-5
Erfurth A, Walden J, Grunze H


Acetazolamide in the treatment of acute mania. A case report
Neuropsychobiology. 1998; 38(3):202-3
Brandt C, Grunze H, Normann C, Walden J


Female genital disorder as adverse symptom of lamotrigine treatment. A serotoninergic effect?
Neuropsychobiology 1998; 38(3):200-1
Erfurth A, Amann B, Grunze H


Renal impairment as a possible side effect of gabapentin. A single case report
Neuropsychobiology. 1998; 38(3):198-9
Grunze H, Dittert S, Bungert M, Erfurth A


Gabapentin in schizoaffective psychosis with acute mania: a case report
Psychiatric Networks. 1998; 1:92-95
Amann B, Rall-Authenrieth H, Erfurth A, Grunze H


Combined treatment with lithium and nimodipine in a bipolar I manic syndrome
Prog Neuropsychopharmacol Biol Psychiatry. 1996; 20(3):419-26
Grunze H, Walden J, Wolf R, Berger M


A calcium antagonist for the treatment of depressive episodes: single case reports
J Psychiatr Res. 1995; 29(1):71-6
Walden J, Fritze J, Van Calker D, Berger M, Grunze H


Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression
Biol Psychiatry. 1995 Nov 1;38(9):611-21
Bauer J, Hohagen F, Gimmel E, Bruns F, Lis S, Krieger S, Ambach W, Guthmann A, Grunze H, Fritsch-Montero R, et al


Einfluss von Immunstimulation durch Endotoxinverabreichung auf klinische und somnographische Parameter bei Patienten mit endogener Depression.
Fortschritte der Neurologie und Psychiatrie 1992; 60 Suppl 2:157
Bauer J, Fritsch- Montero R, Weissbach A, Krieger S, Lis S, Grunze H, Frommberger U, Hohagen F, Berger M


Behandlung von Dekubitalgeschwüren mit kochsalzimpraqnierten Trockenkompressen
Der Allgemeinarzt. 1991; 5:344-348
Grunze H


Myoclonic epileptic seizures during clozapine treatment: a report of three cases
Eur Arch Psychiatry Clin Neurosci. 1991; 240(6):370-2
Gouzoulis E, Grunze H, von Bardeleben U


Kombinierter Dexamethason- Suppressions- und Corticotropin- Releasing- Hormon- Stimulationstest im Krankheitsverlauf bei Patienten mit Depression
Fortschritte der Neurologie und Psychiatrie. 1990; 59 Suppl 1:39
v.Bardeleben U, Weissbach A, Grunze H, HoIsboer F


 

 

Monographien

Monographien

Schizophrenien. Verständnisgrundlagen, Orientierungshilfen, für Patienten und Angehörige
Springer-Verlag, 5. Auflage. 2016
Hell D, Schüpbach D.


Psychopharmaka in der Apotheke
Wissenschaftlicher Verlag. Stuttgart. 2018
Dietmaier O, Schüpbach D.


Bipolare Affektive Störungen- Ursachen und Behandlung
G. Thieme Verlag, Stuttgart. 1.Auflage: 1998, 2.Auflage: 2000, 3.Auflage 2003, 4.Auflage 2006, 5.Auflage 2009
J. Walden, H. Grunze


Bipolare Störungen-Ratgeber für Betroffene und Angehörige
DGBS Eigenverlag, Hamburg, 2002; 2. Überarbeitete Auflage 2005
R. Geislinger, H. Grunze


Valproat bei manisch-depressiven (bipolaren) Erkrankungen
G. Thieme Verlag, Stuttgart, 1.Auflage: 2000 , 2. Überarbeitete Auflage: 2004
H. Grunze, J. Walde


Bipolar Affective Disorder- Etiology and Treatment
G.Thieme Verlag, Stuttgart, 1. Auflage 2000, 2. Auflage 2004
J. Walden, H. Grunze


Die bipolaren Störungen (Manisch-depressive Erkrankungen): Ratgeber für Betroffene und ihre Angehörigen
G. Thieme Verlag, Stuttgart, 2003
H. Grunze
, J. Walden


Untersuchungen an Adsorptionsfilmen zum Grenzflachenverhalten der Hamoglobinkomponente CTT IV von Chironomus thummi thummi in der Luft! Wasser- Grenzschicht mit einem Wilhelmy-Filmwaagesystem
Dissertation, Aachen 1989
H. Grunze


 

 

Buchbeiträge

Buchbeiträge

Agitation due to Substance Use, Abuse and Withdrawl. In Diagnosis and Management of Agitation
Hrsg. M. Zeller, K.Nordstrom, S.Wilson. 3rd ed. Cambridge University Press, Cambridge, 2018, pp 235-238, ISBN 978-1-108-41411-1
A. Schorb, H. Grunze


Chapter 24. Management commentary. In: Parker, G, ed.: Bipolar II Disorder. Modelling, Measuring and Managing
3rd ed. Cambridge University Press, Cambridge, 2018, pp 235-238
ISBN 978-1-108-41411-1
Grunze H


Polypharmazie in der Behandlung bipolarer Störungen. In: Polypharmazie in der Behandlung psychischer Erkrankungen
Hrsg. T.Messer, M.Schmauss. Springer Verlag, Wien New York, 2006, pp 81- 102. 2.Auflage 2009, pp 95-118, 3. Auflage 2016, pp 85-113
H.Grunze, A.Forsthoff, C.Born 


Chapter 40. Bipolar Disorder. In: Zigmond MJ, Rowland LP, Coyle JT, eds. Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders
Academic Press; 2015, pp.655–673
H. Grunze


Pharmacotherapy and dual disorders .In: Co-occurring addictive and psychiatric disorders: a practice based handbook on dual disorders within the European healthcare context
Hrsg. G.Dom, F.Moggi. Springer Verlag, New York, 2015, 279-306
M.Soyka, H.Grunze


Chapter 23. Pharmacological Treatment of Acute Bipolar Depression. In: Bipolar Disorder: Millenium Update. Hrsg. A.Yildiz, C.Nemeroff, P.Ruiz
Oxford University Press, New York, 2015, pp.281-298
K. Gao, R.Wu, H. Grunze, JR Calabrese


Chapter 32. Treatment Induced Mood Instability: Treatment – Emergent Affective Switches and Cycle Acceleration. In: Bipolar Disorder: Millenium Update
Hrsg. A.Yildiz, C.Nemeroff, P.Ruiz. Oxford University Press, New York, 2015,pp.417-434
R.Wu, K. Gao, JR Calabrese, H. Grunze


Long-term treatment of mood disorders: follow-up of acute treatment phase studies versus continuation and maintenance phase studies, and enriched versus non-enriched designs. In: Clinical Trial Design Challenges In Mood Disorders
Hrsg. M.Tohen, C.Bowden, A.Nierenberg, J.Geddes. Elsevier, Amsterdam, 2015, pp 29-47
W.A. Nolen, H. Grunze.


Optionen der Langzeittherapie bipolarer Verläufe. In: H.J.Assion, P.Brieger, M.Bauer: Bipolare Störungen. Das Praxishandbuch
Verlag W.Kohlhammer, Stuttgart 2013, pp. 167-175
H.Grunze, J.Walden


Chapter 14: The role of polypharmacy in Bipolar Disorder treatment guidelines. In: Polypharmacy in psychiatry practice, Vol II.
Hrsg. M.Ritsner. Springer Verlag, New York, 2013 pp.275-287
H.Grunze


Medikamente zur Behandlung bipolarer Störungen. In: Handbuch der Psychopharmakotherapie, 2. Auflage
Hrsg. G.Gründer, O.Benkert.Springer Verlag, Berlin-Heidelberg, 2012, pp 629-658
H.Grunze, M.Bauer


Carbamazepine, Other Anticonvulsants and Augmenting Agents. In: Bipolar Psychopharmacology-Caring for the patient
Hrsg.H.S. Akiskal, M.Tohen. John Wiley & Sons, Chichester, 1.Auflage 2005, pp 63-84: 2.Auflage: 2011, pp 61-78
H.Grunze


The treatment of mania. In: Practical management of bipolar Disorder
Hrsg. A.H.Young,I.N.Ferrier, E.E.Michalak. Cambridge University Press, 2010, pp 10-23
H.Grunze


Bipolar Disorder. In: McGraw-Hill Yearbook of Science & Technology 2010
Hrsg.  M.Licker et al. McGraw-Hill, New York,2010, pp 48-50
H.Grunze


Medikamente zur Behandlung bipolarer affektiver Störungen. In: Handbuch der Psychopharmakotherapie
Hrsg. F.Holsboer, G.Gründer, O.Benkert.Springer Verlag, Berlin-Heidelberg, 2008, pp 555-590
H.Grunze, A.Forsthoff


Mood Disorders: Depression. In : Psychiatry, Third Edition
Hrsg. A.Tasman,J.Kay, J.A.Lieberman.M.B.First.M.Maj. Wiley-Blackwell, Chichester 2008, pp 1283- 1331
H.Grunze,C. Schüle, D.Casey, T.C. Baghai


Modul Therapie akuter Episoden. In: Weissbuch bipolare Störungen in Deutschland
Hrsg. Deutsche Gesellschaft für Bipolare Störungen e.V. Eigenverlag 2002, pp 57-66; 2.Auflage  2003, pp89-130. 3.Auflage 2006, pp 161-206
H.Grunze, M.Dobmeier


Medikamentöse Therapie der Manie. In: Therapie psychischer Erkrankungen
Hrsg. H.J.Möller, G.Thieme Verlag, Stuttgart-New York,1999, pp 321-334; 3. vollständig überarbeitete Auflage 2006, pp.351-363
H.Grunze


Antikonvulsiva. In:  Akute und therapieresistente Depressionen
2.Auflage Hrsg. M.Bauer, A.Berghöfer, M.Adli. Springer Verlag, Heidelberg,2005,pp273-284
F.Seemüller, H.Grunze


Quetiapin in der Langzeitherapie bipolarer Störungen. In: Das Quetiapin-Dossier. Pharmakologie,Indikationen, therapeutische Erfahrungen.
Hrsg. H.J. Möller. Schattauer Verlag, Stuttgart, 2005, pp 121-130
H.Grunze


Is there a role for Typical Neuroleptics in bipolar disorder ? In: Handbook of Bipolar disorder
Hrsg. S.Kasper, R .M. Hirschfeld.Taylor& Francis, New York- London 2005, pp331- 338
H.J.Möller, H.Grunze


Toward an Integrated view: Algorithms in Bipolar disorder. In: Handbook of Bipolar disorder
Hrsg. S.Kasper, R .M. Hirschfeld.Taylor& Francis, New York- London 2005, pp 435-446
H.Grunze


Biological aspects of rapid-cycling and mixed states. In: Bipolar Disorders- Mixed states,Rapid cycling and atypical forms
Hrsg. A.Marneros, F.Goodwin. Cambridge University Press, New York, 2005, pp311-323
H.Grunze, J.Walden


Biologische Behandlungsmethoden. In: Das Neue Handbuch der bipolaren und Depressiven Erkrankungen
Hrsg. A.Marneros. G.Thieme Verlag, Stuttgart-New York 2004, pp 225-267
H.J.Möller, M.Schmauss, H.Grunze


Biologische Grundlagen. In: Das Neue Handbuch der bipolaren und Depressiven Erkrankungen
Hrsg. A.Marneros. G.Thieme Verlag, Stuttgart-New York 2004, pp 387-402
H.Grunze, A.Rohde, A.Marneros


Elektrokonvulsionstherapie der manischen Episode im Rahmen einer bipolaren affektiven Störung. In: Elektrokunvulsionstherpie-klinische und wissenschaftliche Aspekte
Hrsg. T.C.Baghai, R.Frey,S.Kasper, H.J.Möller.Springer, Wien-New York, 2004, pp 394-405
H.Grunze, J.Scharfetter


Bipolare Störungen. In: Psychotische  Störungen
Hrsg. P.Falkai, F.G. Pajonk. G.Thieme Verlag, Stuttgart, 2003, pp 65-78
H.Grunze


Bipolare Erkrankungen-sind moderne Neuroleptika eine neue Option?
6. Bad Homburger ZNS-Gespräche, 2003, 17-18
H.Grunze


The search for the Holy Grail- The ideal mood stabilizer: Fiction or Future. In: Bipolar Disorder. WPA Series Evidence and Experience in Psychiatry
Hrsg. M.Maj,  H.S.Akiskal,  J.J.Lopez-Ibor,  N.Sartorius. Wiley, Chichester 2002, pp 229-232
H.Grunze


New anticonvulsants in Bipolar Disorder: Lamotrigine, Gabapentin, Topiramate. In: Seizures, Affective Disorders and Anticonvulsant Drugs
Hrsg. M.Trimble, B.Schmitz. Clarius Press, Guildford 2002, pp 131-142
J.Walden, H. Grunze


How might anticonvulsant drugs work in bipolar affective disorder ?  In: Seizures, Affective Disorders and Anticonvulsant Drugs
Hrsg. M.Trimble, B.Schmitz. Clarius Press, Guildford 2002, pp 117- 130
H.Grunze, B.Amann, J.Walden


Erhaltungstherapie/Rezidivprophylaxe mit Antidepressiva. In: Neuro Psychopharmaka Band 3: Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer
2. Neubearbeitete Auflage. Hrsg. P.Riederer, G.Laux, W. Pöldinger. Springer, Wien-New York 2002, pp 651-661
H.J. Möller, H.Grunze


Carbamazepin/Valproat: 13.2.Pharmakologie, 13.3. Neurobiochemie, Wirkmechanismus, 13.4. Klinik. In:  Neuro Psychopharmaka Band 3: Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer
2. Neubearbeitete Auflage. Hrsg. P.Riederer, G.Laux, W. Pöldinger. Springer, Wien-New York 2002, pp 866-895
J.Walden, H.Grunze


Exkurs: Potentielle neue Behandlungsmöglichkeiten bipolarer affektiver Störungen. In: Neuro Psychopharmaka Band 3: Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer
2. Neubearbeitete Auflage. Hrsg. P.Riederer, G.Laux, W. Pöldinger. Springer, Wien-New York 2002, pp 896- 902
H.Grunze, J.Walden


Valproinsäure in der Behandlung des manischen Syndroms und in der Prophylaxe bipolarer affektiver Störungen. In: Valproinsäure. Pharmakologie,Klinischer Einsatz, Nebenwirkungen und Therapierichtlinien
2.Auflage. Hrsg. G.Krämer, J.Walden. Springer Verlag, Berlin-Heidelberg, 2002, pp 248-255
J.Walden, C.Normann, J.Langosch, A.Erfurth, H.Grunze


Valproinsäure zur Behandlung von „rapid cycling“ und dysphorischer Manie. In: Valproinsäure.  Pharmakologie,Klinischer Einsatz, Nebenwirkungen und Therapierichtlinien
2.Auflage. Hrsg. G.Krämer, J.Walden. Springer Verlag, Berlin-Heidelberg,2002, pp 256-263
A.Erfurth, H.Grunze, J.Walden


Intravenöse Valproinsäure-Behandlung bei bipolaren Störungen. In: Valproinsäure.  Pharmakologie, Klinischer Einsatz, Nebenwirkungen und Therapierichtlinien
2.Auflage. Hrsg. G.Krämer, J.Walden. Springer Verlag, Berlin-Heidelberg, 2002, pp 264-274
H.Grunze,A.Erfurth,B.Amann,J.Walden


Antidepressant treatment of bipolar depression. In: Bipolar disorders-100 years after manic depressive insanity
Hrsg. A.Marneros, J.Angst. Kluwer Academic Publishers, Dordrecht, 2000, pp 387-404
H.J.Möller, H.Grunze


Bedeutung der Antiepileptika in der psychiatrischen Therapie. In: Spektrum psychiatrischer Arbeit
Hrsg. K.Peter Springer Verlag Wien-New York, 2000,pp.67-74
J.Walden,C.Normann,J.Langosch,M.Berger, H.Grunze


Clinical trials of bipolar disorder. Applications and limitations. In: Anticonvulsants in Psychiatry- Round table series 64
Hrsg. N. Sussman. Royal Society of Medicine Press Ltd 1999, London, pp 17-20 (ISBN-10: 1853153788, ISBN-13: 978-1853153785)
J.Walden, H. Grunze


Störungen der glutamatergen Aktivierung limbisch-kortikaler Interneurone- ein zelluläres Psychosemodell ? In: Schizophrenie- Moderne Konzepte zu Diagnostik, Pathogenese und Therapie
Hrsg. H.J.Möller, N.Müller. Springer Verlag, Wien-New York, 1998, pp127-142
H.Grunze, C.Kammerer


Bedeutung des Calciumantagonismus in der Therapie der Epilepsien und affektiven Störungen. In: Aktuelle Perspektiven der Biologischen Psychiatrie
Hrsg. H.J.Möller, F.Müller-Spahn, G.Kurtz, Springer Verlag, Wien -New York, 1996, pp 797-800
J.Walden, D.Van Calker, J.von Wegerer, H.Grunze


Calcium antagonism as a possible common mechanism of carbamazepine effects in epilepsy and psychiatric disorders, In: Proceedings of the Second International Conference on refractory Depression (Amsterdam 1992)
Hrsg. J.Zohar,S.P.Roose, W.A.Nolen. J.Wiley &Sons, London 1992
H.Grunze,J.Walden,D.Bingmann,M.Berger


Neurophysiologische Aspekte der Wirkung von Carbamazepin. In: Neue Aspekte zur Diagnostik und Therapie affektiver Störungen
Hrsg. H.P.Wunderlich, W.Zuckschwerdt Verlag, München-Bern-Wien-San Franzisco, 1991,pp 14-26
J.Walden,  E.J.Speckmann, D.Bingmann, U.Altrup, G.Eikmeier, H.Grunze, M.Gastpar

Reviews (R), Short Reports (SR), Fallberichte (FB), Sonstige (S)

Reviews (R), Short Reports (SR), Fallberichte (FB), Sonstige (S)

Predictors of Psychosocial Outcome of Bipolar Disorder: Results from the Stanley Foundation Bipolar Network
The Lancet Psychiatry 2018, submitted
Bennett F, Sophie Hodgetts S, Altshuler L, Close A, Frye M, Grunze H, Keck P, Kupka R, Leverich G, McElroy S, Nolen W, Post R, Schärer L, Suppes T, Sharma A


Extrapyramidal symptoms in schizophrenia: evidence of blunted cerebral hemodynamics during a planning task
International Clinical Psychopharmacology. 32:225–230. 2017 (SR)
Schuepbach D, Michel M, Wagner G, Duschek S, Herpertz SC


Hydrocephalus, psychosis and art: a case report
Schweizer Archiv für Neurologie und Psychiatrie, 166, 23-25. 2015 (FB)
Noll S, Boeker H, Roth-Greminger G, Hoff P, Schuepbach D


Arachnoid cyst in a patient with bipolar disorder: Just an incidental finding? Schweizer Archiv für Neurologie und Psychiatrie, 164, 252-254. 2013 (FB)Claussen MC, Rohde J, Seifritz E, Schuepbach D


Combined symptomatology of psychosis, pica syndrome, and hippocampal sclerosis: a case reportInternational Journal of Eating Disorders, 46, 89-91. 2013 (FB)
Rohde J, Claussen MC, Kuechenhoff B, Seifritz E, Schuepbach D


Pharmakotherapie der Bipolaren Störungen und der Manie
Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 62, 243-254. 2014 (R)
Schuepbach D, Seifritz E


BPS Fortbildungsmodul I: Aktuelle Aspekte der Diagnose und Therapie Bipolarer Störungen
Sanofi-Aventis 2006
H.Grunze


Interview Orfiril® long – Zulassung jetzt bei akuter Manie und zur Prophylaxe bipolarer Störungen
Neuronews 2005; 4- Juni -ISSN 1619-7577
H.Grunze


Bipolare Störungen. Fortbildungs-Medien-Akademie Psychiatrie
CME zertifiziere Fortbildungs–DVD. 2.Auflage, 2004
H.Grunze


Interview Expertenmeinung: Bipolare Störungen-Praxisbezogene Therapie
Psycho 2004; 5: 6-7
H.Grunze


Nachgefragt bei Dr.Heinz Grunze, 1.Vorsitzender der DGBS: Individuelle Therapiestandards (Interview)
Der Neurologe und Psychiater (DNP) 2003; 12: 7
H. Grunze


Meeting report-The 151st Annual Meeting of the American Psychiatric Association
Journal of Bipolar Disorder 1998,2 (2) 41-45  (ISSN 1460-0579)
H.Grunze:


Bachelor

Bachelor

Konflikte im Team aufdecken – Führungsinstrumente nutzen

Frau Britta Oecknigk, Studiengang Gesundheits,- und Sozialmanagement (B.A.) an der HFH (Hamburger Fernhochschule


Stationsäquivalente gerontopsychiatrische Akutbehandlung in der Häuslichkeit. Der Wunsch der Angehörigen und die Bedeutung für die Organisation

Herr Andreas Böttinger, Studiengang Pflegemanagement und Organisationswissen B.A. (Fliedner Fachhochschule Düsseldorf)

Master

Master

Die Seite befindet sich momentan im Aufbau

Fachpflege

Fachpflege

Die Seite befindet sich momentan im Aufbau.

Übersichtsarbeiten

Übersichtsarbeiten

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder
World Journal of Biological Psychiatry 2018; 19(1):2-58.
PMID: 29098925
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Azorin JM, Yatham L, Mosolov S, Möller HJ, Kasper S; Members of the WFSBP Task Force on Bipolar Affective Disorders Working on this topic


Bipolare Störungen und Sucht.
DNP 2018,19(5), 40-47
Grunze H, Heinrich T, Walden J.


Kommentar zu “ Akutwirksamkeit von antidepressiven Therapien unter der Lupe“
Dtsch Med Wochenschr.2018;143, 1149-1150
Grunze H


Nebenwirkungen von Psychopharmaka: Tipps für die Praxis.
Dtsch Med Wochenschr. 2017;142(22):1690-1700.
PMID: 29078215
Grunze A, Mago R, Grunze H.


Expertenkonsensus zum Assessment und Management der psychomotorischen Agitation.
PPT 2017, 24(4)142-159
Messer T, Naber D, Möller HJ, Grunze H, Garriga M, Vieta E, Kasper S.


The International College of Neuropsychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), Part 1: background and methods of the development of guidelines
Int J Neuropsychopharmacol. 2017;20(2):98-120.
PMID: 27815414
Fountoulakis K, Young A, Yatham L, Grunze H, Vieta E, Blier P, Möller HJ, Kasper S


The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), Part 2: Review, grading of the evidence and a precise algorithm
Int J Neuropsychopharmacol. 2017;20(2):121-179.
PMID: 27816941
Fountoulakis K, Yatham L, Grunze H, Vieta E, Young A, Blier P, Kasper S, Möller HJ


The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), Part 3: The clinical guidelines
Int J Neuropsychopharmacol. 2017;20(2):180-195.
PMID:27941079
Fountoulakis K, Grunze H, Vieta E,  Young A, Yatham L, Blier P, Kasper S, Möller HJ


The International College of Neuropsychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), Part 4: Unmet needs in the treatment of Bipolar disorder and recommendations for future research
Int J Neuropsychopharmacol. 2017;20(2):196-205.
PMID: 27677983
Fountoulakis K, Vieta E,  Young A, Yatham L, Grunze H, Blier P, Möller HJ, Kasper S


Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines
Int J Psychiatry Clin Pract. 2017;21(3):166-176.
PMID: 28367707
Garrig Bauer M, Severus E, Möller HJ, Young AH; WFSBP Task Force on Unipolar Depressive Disorders


Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
J Psychopharmacol. 2016;30(6):495-553.
PMID:26979387
Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes T, Cipriani A, Coghill DR, Fazel S, Geddes JR, Grunze H, Holmes EA, Howes O, Hudson S, Hunt N, Jones I, Macmillan IC, McAllister-Williams H, Miklowitz DR, Morriss R, Munafo M, Paton C, Saharkian BJ, Saunders K, Sinclair J, Taylor D, Vieta E, Young AH


DNP Serie Off Label Therapien Psychischer Erkrankungen, Teil 4: Affektive Störungen
Der Neurologe und Psychiater (DNP) 2016, 17 (7-8): 30-33
Erratum und Addendum: Off-Label bei Manie und Depression? DNP 2016; 17 (11):32 – 33
Grunze H


Bipolare Mischzustände - eine Herausforderung in der Diagnostik und Therapie
Jatros Neurologie & Psychiatrie 2016;, 6,12-15
Grunze H.


World Federation of Societies of Biological Psychiatry (WFSBP)  Consensus. Assessment and management of agitation in psychiatry: Expert Consensus
World Journal of Biological Psychiatry, 2016;17: 86-128 
PMID:26912127

Garriga M, Pacchiarotti I, Kasper S, Zeller S, Allen MH,Vazquez G, Baldacara L, San L, McAllister-Williams RH, Fountoulakis KN, Courtet P, Naber D, Chan EW, Fagiolini A, Möller HJ, Grunze H, Llorca PM, Jaffe RL, Yatham LN, Mazzei DH, Passamar M, Messer T, Bernardo M, Vieta E


Acute pharmacological treatment strategies for bipolar depression
Neuropsychiatry 2016; 6(3), 96–111
Mohammed Z, Grunze H


Gesundheitsvorsorge bei bipolaren Patienten: eine Übersicht zu den verschiedenen Empfehlungen.
Jatros Neurologie Psychiatrie 2015; 5, 16-20
Mühlbacher M, Geretswegger C, Grunze H


Safety and tolerability of anticonvulsant medication in bipolar disorder
Expert Opin Drug Saf. 2015 Nov;14(11):1703-24
Pichler E, Hattwich G, Grunze H, Mühlbacher M


Long-acting injection antipsychotic medications in the management of schizophrenia.
Evidence based Psychiatric Care  2015; 1:27-36
Sacchetti E, Grunze H, Leucht S, Vita A


Pharmakotherapie komorbider schizophrener und bipolarer Psychosen.
Suchtmedizin 2014;16(2),61-67
Grunze H, Soyka M


Stimulants for Treating Bipolar Disorder: Pro and Con
Harvard Review of Psychiatry 2014; 22 (6): 358–362
Grunze H


Invited comment: "Bipolar disorder: not another meta-analysis"
The Lancet Psychiatry 2014, in press
Grunze H


Coping style and bipolarity (Editorial)
Acta Neuropsychiatrica  2014;26 (2): 67-68
Grunze H


Deeskalationstechniken und atypische Neuroleptika in der Behandlung der akuten Manie.
Fortschr.Neurol.Psychiatr. 2013; 81 Suppl 1:S9-16.
Amann BL, Wesuls R, Landin- Romero R, Grunze H.


Herausforderungen der ambulanten Behandlung von Patienten mit bipolar-affektiven Stoerungen.
Fortschr.Neurol.Psychiatr. 2013; 81 Suppl 1:S35-39
Seemuller F, Berger M, Musil R, Severus E, Dittmann S, Born C, Schaub A, Dargel S, Grunze H.


Kognitiv-psychoedukative Gruppenintervention bei bipolar erkrankten Patienten:  Pilotstudie mit Zwei-Jahres-Katamnese.
Fortschr.Neurol.Psychiatr. 2013; 81 Suppl 1:S30-34
Schaub A, Neubauer N, Bernhard B, Born C, MoEller HJ, Grunze H.


Differenzialdiagnostik und Psychopharmakotherapie bipolarer Stoerungen.
Fortschr.Neurol.Psychiatr. 2013; 81 Suppl 1:S3-8.
Grunze H, Grunze A, Amann BL.


Bildgebende Verfahren bei bipolaren Erkrankungen.
Fortschr.Neurol.Psychiatr. 2013; 81 Suppl 1:S17-21.
Grunze A, Meisenzahl E, Grunze H.


Task Force report on antidepressant use in bipolar disorders
Am.J.Psychiatry.2013; 170:1249-62
Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Ghaemi SN,  et al The International Society for Bipolar Disorders (ISBD)


World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders
World J.Biol.Psychiatry. 2013;14:334-385
Bauer M, Pfennig A,  Severus E, Whybrow PC, Angst J, Moeller HJ, Task Force on Unipolar Depressive Disorders


Physical health of patients with bipolar disorder
Acta Psychiatr.Scand.Suppl. 2013;442:3-10
Young AH, Grunze H


The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2012 on the Long-term Treatment of Bipolar Disorder
World J Biol Psychiatry. 2013; 14:154-219
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S


Sind atypische Antipsychotika Mittel erster Wahl bei bipolaren Storungen?
Pro. Nervenarzt. 2012; 83(9):1190
Grunze H
.


Treatment options for acute depression in bipolar disorder
Bipolar Disord. 2012; 14 Suppl 2:37-50
Bauer M, Ritter P, Grunze H, Pfennig A


Comparative efficacy of anti-manic drugs in acute mania
Lancet. 2012: 10;379(9819):893
Grunze H, Fyans P


Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance
Curr Med Res Opin. 2011; 27(12):2285-99
Goodwin GM, Abbar M, Schläpfer TE, Grunze H, Licht RW, Bellivier F, Fountoulakis KN, Altamura AC, Pitchot W, Ågren H, Holsboer-Trachsler E, Vieta E


At the edge of the bipolar spectrum: primacy of affective over psychotic symptoms or vice versa?
World Psychiatry. 2011; 10(3):197-8
Grunze H


The clinical side of bipolar disorders
Pharmacopsychiatry. 2011; 44 Suppl 1:43-8
Grunze H


Bipolar disorder--a focus on depression.
N Engl J Med.2011; 21:364(16):1581
Vieta E, Grunze H


Quetiapine is effective in the treatment of adults in the acute phase of bipolar depression
Evid Based Ment Health. 2010; 13(3):88
Grunze HC


Anticonvulsants in bipolar disorder
J Ment Health. 2010; 19(2):127-41
Grunze HC


Akut- und Langzeittherapie der bipolaren Depressionen.
Nervenarzt. 2010; 81(5):539-48
Grunze H, Dargel S.


Behandlung Bipolarer Depressionen: Nur noch „Mood Stabilizer“?
INFO Neurologie & Psychiatrie 2010; 12 (11):10
Grunze H.



Bipolare Depressionen: Weitere Evidenz für den Einsatz eines Atypikums.
INFO Neurologie & Psychiatrie 2010; 12 (7-8):8-9
Grunze H.


The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression
World J Biol Psychiatry. 2010; 11(2):81-109
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S; WFSBP Task Force On Treatment Guidelines For Bipolar Disorders


Clausius N, Born C, . Die Bedeutung von Dopaminagonisten in der Behandlung der Depression.
Neuropsychiatr. 2009; 23(1):15-25.
Grunze H


Stellenwert atypischer Antipsychotika bei bipolaren Störungen.
Der Neurologe und Psychiater (DNP) 2009; 10:52-56
Grunze H. und Walden J


Aripiprazol bei akuter Manie: Auch mittelfristig lohnend.
INFO Neurologie & Psychiatrie 2009; 11 (4):28
Grunze H.


Verminderung von oxidativem Stress – ein neuer Ansatz bei bipolaren Depressionen ?
INFO Neurologie & Psychiatrie 2009; 11 (2):22
Grunze H.


Spezifische Behandlungsaspekte bipolar erkrankter Frauen.
Nervenarzt. 2009; 80(3):263-72.
Sasse J, Pilhatsch M, Forsthoff A, Grunze H, Neutze J, Pfennig A, Schmitz B, Schwenkhagen A, Bauer M.


Invited comment on Licht et al “How to manage mania not responding to a first-step 2 weeks treatment with quetiapine – a report from a prematurely discontinued randomised clinical trial”Acta Psychiatr Scand. 2009; 120(4):335
Grunze H


Anticonvulsants in the treatment of aggression in the demented elderly:an update
Clin Pract Epidemiol Ment Health. 2009; 16(5):14
Amann B, Pantel J, Grunze H, Vieta E, Colom F, Gonzalez-Pinto A, Naber D, Hampel H


The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania
World J Biol Psychiatry. 2009; 10(2):85-116
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S


The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders
Bipolar Disord. 2009; 11(5):453-7
Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S, Berk M


Nur depressiv oder bipolar erkrankt? Fragen Sie nach Zeichen einer Hypomanie oder Manie!
MMW Fortschr Med. 2008; 19:150 Suppl 2:37-40
Grunze H, Forsthoff A.


Die oft schwierige Langzeitbehandlung mit Antidepressiva (Editorial)
Der Neurologe und Psychiater (DNP) 2008; 9 (5): 1-2
Grunze H.


Hemmung der Proteinkinase C. Innovativer Ansatz bei Manie?
INFO Neurologie & Psychiatrie 2008; 10 (6):20
Grunze H.


Contra-Neue Mood stabilizer- Eine Chance für die individuelle Pharmakotherapie.
Psychiatrie und Psychotherapie up2date 2008,2(5), 280-281
Grunze H.


Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation?
CNS Spectr. 2008; 13(9):790-5
Grunze HC


Treatment of bipolar depression: an update.
J Affect Disord. 2008; 109(1-2):21-34
Fountoulakis KN, Grunze H, Panagiotidis P, Kaprinis G.


The effectiveness of anticonvulsants in psychiatric disorders.
Dialogues Clin Neurosci. 2008; 10(1):77-89.
Grunze HC


Are bipolar mood symptoms affected by the phase of the menstrual cycle?

J Womens Health (Larchmt). 2008 Apr;17(3):473-8.
Shivakumar G, Bernstein IH, Suppes T; Stanley Foundation Bipolar Network, Keck
PE, McElroy SL, Altshuler LL, Frye MA, Nolen WA, Kupka RW, Grunze H, Leverich GS,
Mintz J, Post RM.


Antiepileptika in der Therapie bipolarer Störungen
Neuropsychiatr. 2007; 21(2):110-20.
Grunze H.


Valproinsäure- Ergebnisse bei der Behandlung bipolarer affektiver Störungen. Eine aktuelle Studienübersicht.
PPT 2007, 14 (2), 47-64
Grunze H.


Klinischer Stellenwert der Valproat-Therapie bei bipolaren Störungen.
Fortschr Neurol Psychiatr. 2007; 75(4):220-35.
Grunze H, Adli M, Bauer M, Berger M, Bergmann A, Bräunig P, Bschor T, Falkai P, Gastpar M, Greil W, Kasper S, Krüger S, Laux G, Müller WE, Naber D, Walden J.


Atypikum zur Rezidivprophylaxe der Manie:Was in der Akutphase gut tut, schützt auch vor dem Rückfall.
INFO Neurologie & Psychiatrie 2007; 9 (1):26-7
Grunze H.


Kombinationstherapie bei Manie- Warum bildet eine Studie nicht ab, was als optimale Therapie gilt ?
INFO Neurologie & Psychiatrie 2007; 9 (1):22-3
Grunze H.


Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence.
Int J Neuropsychopharmacol. 2007; 10 Suppl 1:1-207.
Sartorius N, Baghai TC, Baldwin DS, Barrett B, Brand U, Fleischhacker W, Goodwin G, Grunze H, Knapp M, Leonard BE, Lieberman J, Nakane Y, Pinder RM, Schatzberg AF, Svestka J, Baumann P, Ghalib K, Markowitz JC, Padberg F, Fink M, Furukawa T, Fountoulakis KN, Jensen P, Kanba S, Riecher-Rössler A. 


Antiepileptic drugs and mood stability.
Clin EEG Neurosci. 2007; 38(2):116-23.
Amann B, Grunze H, Vieta E, Trimble M.


Treatment of Acute Bipolar Depression: A European Viewpoint.
J of Bipolar Disorders 2007;5(4), 3,17
Grunze H.


Recent Advances in the Treatment of Bipolar Depression.
Clinical Approaches in Bipolar Disorders 2007; 6: 20-27
Farrelly N, Sachs G, Möller H-J, Grunze H.


Rezidivprophylaxe bipolarer Erkrankungen.
Psychiatr Prax. 2006; 33 Suppl 1:47-54.
Sterr A, Amann B, Grunze H.


Valproat bei der akuten Maniebehandlung- Hoch dosieren und rasch auftitrieren?
INFO Neurologie & Psychiatrie 2006; 8 (3):33
Grunze H.


Wenig Erkenntnisgewinn, aber viele offene Fragen.
Neuropsychiatr. 2006; 20 (1):4-6
Grunze H, Möller H, J. CATIE


Leitlinien zur Therapie der akuten Manie.
Psychiatr Prax. 2006; 33 Suppl 1:2-6
Krüger S, Bräunig P, Grunze H.


Therapietabellen für den Praxisgebrauch.Bipolare Störungen.
Neurotransmitter 2006,Sonderheft 3, 5-13
Schweiss I, Grunze H


Atypical Antipsychotics in Bipolar Disorder.
Hospital Pharmacy Europe 2006, 25, 13-15
Grunze H.


WFSBP Task force on Treatment Guidelines for Bipolar Disorder: WFSBP
Guidelines for Biological Treatment of Bipolar Disorders part 1-Treatment of Bipolar depression. European Neurological Review 2006, 6(1):77-82
Grunze H, Kasper S, Goodwin G, Bowden C, baldwin D, Licht R, Vieta E, Möller HJ,


New findings from the Bipolar Collaborative Network: clinical implications for therapeutics.
Curr Psychiatry Rep. 2006; 8(6):489-97.
Post RM, Altshuler LL, Frye MA, Suppes T, McElroy S, Keck PE Jr, Leverich GS, Kupka R, Nolen WA, Grunze H.


depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.
Eur Arch Psychiatry Clin Neurosci. 2006; 256(1):1-16.
Möller HJ, Grunze H, Broich K.


Bipolare affektive Störungen: Wie lassen sich neue Episoden vermeiden?
Extracta psychiatrica/ neurologica 2006,1-2, 19-23
Seemüller F, Dittmann S, Forsthoff A,  Bernhard B, Grunze H


Breites Spektrum möglicher Ursachen Bipolarer Störungen. Forschungsansätze und Hypothesen.
Der Neurologe und Psychiater (DNP) 2005; Sonderheft 1; 6-8
Forsthoff A, Grunze H


Bipolare Störungen erkennen. Die Kunst der korrekten Diagnose.
Der Neurologe und Psychiater (DNP) 2005; Sonderheft 1; 8-9
Grunze H, Severus E


Bewährte und neue Optionen bei Bipolaren Störungen. Therapie der akuten Manie.
Der Neurologe und Psychiater (DNP) 2005; Sonderheft 1; 10-14
Forsthoff A, Grunze H


Therapeutische Optionen bei Manie und Depression. Labile Stabilität.
Der Neurologe und Psychiater (DNP) 2005; Sonderheft 1; 15-17
Born C, Dittmann S, Grunze H


Prophylaxe und Langzeittherapie Bipolarer Störungen. Risiken minimieren.
Der Neurologe und Psychiater (DNP) 2005; Sonderheft 1; 17- 20
Seemüller F, Bernhard B, Grunze H


Ergenylchronosphere bei Bipolaren Störungen.
Krankenpfl J. 2005; 43(7-10):213
Grunze H.


Bipolare Störungen differenziert behandeln: Manie, Depression oder Mischzustand?
MMW Fortschr Med. 2005; 17:147 Spec No 2:32-6
Forsthoff A, Born C, Grunze H.


Bipolare Störungen-State of the art.
PharmaFokus ZNS 2005; 2: 27-28
Grunze H


Behandlungsresistente Schizophrenie-verbessert D-Serin die response auf atypische Antipsychotika?
INFO Neurologie & Psychiatrie 2005; 7 (6):29-30
Grunze H


Is the prophylactic antidepressant efficacy of lithium in bipolar I disorder dependent on study design and lithium level?
J Clin Psychopharmacol. 2005; 25(5):457-62.
Severus WE, Grunze H, Kleindienst N, Frangou S, Möller HJ.


The safety and tolerability of atypical antipsychotics in bipolar disorder.
Expert Opin Drug Saf. 2005; 4(5):849-68
Seemüller F, Forsthoff A, Dittmann S, Born C, Bernhard B, Severus WE, Grunze H.


Atypical antipsychotics in bipolar depression: potential mechanisms of action.
J Clin Psychiatry. 2005;66 Suppl 5:40-8
Yatham LN, Goldstein JM, Vieta E, Bowden CL, Grunze H, Post RM, Suppes T, Calabrese JR.


Reevaluating therapies for bipolar depression.
J Clin Psychiatry. 2005; 66 Suppl 5:17-25.
Grunze H


A rare form of bipolar disorder-48h Ultra-Rapid cycling.
CABD 2005,4: 60-63
Juckel H, Hegerl U, Mavrogiorgou P, Bauer M, Grunze H, Möller HJ.


Newer prophylactic agents for bipolar disorder and their influence on suicidality.
Arch Suicide Res. 2005; 9(3):301-6
Born C, Dittmann S, Post RM, Grunze H.


Antiepileptic drugs in mood-disordered patients.
Epilepsia. 2005; 46 Suppl 4:38-44.
Gajwani P, Forsthoff A, Muzina D, Amann B, Gao K, Elhaj O, Calabrese JR, Grunze H.


A European perspective on the Canadian guidelines for bipolar disorder.
Bipolar Disord. 2005; 7 Suppl 3:73-6
Vieta E, Nolen WA, Grunze H, Licht RW, Goodwin G


Neurochemical underpinnings in bipolar disorder and epilepsy.
Epilepsia. 2005; 46 Suppl 4:26-30
Born C, Seemüller F, Grunze H.Quetiapine: an approach for the treatment of bipolar disorders. Future Neurology 2005:1 (2),131-138
Amann B, Grunze H.


Pro/Con- Classical Neuroleptics are still relevant for mania.
The Journal of Bipolar Disorders 2005,4(2) 3,15-16
Grunze H
, Tohen M

Lamotrigin in der Behandlung von Patienten mit Bipolar I und Bipolar II Störungen.
Psychopharmakotherapie. 2004; 11 (2):42-49
Schön S,


SSRI-resistente Depression- Hilft die zusätzliche Gabe eines Betablockers?
Info Neurologie & Psychiatrie 2004, 6 (6), 7-8
Forsthoff A, Grunze H


Welche Rolle spielen Atypika in der Therapie bipolarer Störungen?
Neuropsychiatrische Nachrichten 2004,7,10
Grunze H


Zum Stellenwert von Bupropion in der Depressionsbehandlung.
Psychoneuro 2004; 30(10): 557–558
Langosch J, Grunze H


Langzeitbehandlung Bipolarer Störungen: Viel spricht für einen frühen Beginn.
Der Neurologe und Psychiater (DNP) 2004; 10:22-25
Walden J und Grunze H.


Bipolare Störungen: Mischzustände erkennen und gezielt behandeln.
Der Neurologe und Psychiater (DNP) 2004; 7-8:49-53
Severus E, Forsthoff A, Grunze H.


Den Dialog mit den Patienten intensivieren! (Editorial)
Der Neurologe und Psychiater (DNP) 2004; 6:1
Grunze H.


Therapie bipolarer Störungen- Neue Zulassungen erweitern das Spektrum.
Neurotransmitter  2004;5: 2-9
Schweiss I, Grunze H.


Bei jeder Depression immer auch an bipolare Erkrankungen denken. Die verkannte Manie.
MMW Fortschr Med. 2004; 24:146 Spec No 2:4-6, 8
Grunze H, Sasse J, Forsthoff A, Bauer M.


Diagnostik und Therapie der bipolaren Erkrankung. Die Suizidgefahr erkennen und bannen.
MMW Fortschr Med. 2004; 24:146 Spec No 2:2-5
Grunze H, Sasse J, Forsthoff A, Bauer M.


WFSBP Task Force on Treatment Guidelines for Bipolar Disorders.
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry. 2004; 5(3):120-35.
Grunze H, Kasper S, Goodwin G, Bowden C, Möller HJ


Editorial-The burden of bipolar disorder.CABD 2004;3:3
Grunze H.


A Long-term monotherapy or combination therapy in Bipolar Disorder.
Pole 2 pole Journal on Mood Disorders 2004, 2 (3), 8-11
Grunze H, Forsthoff


Olanzapin (Zyprexa)--zuverlässig in Akuttherapie, Ruckfallschutz und bei der langfristigen Stimmungsstabilisierung.
Krankenpfl J. 2003; 41(10-12):225
Grunze H.


Therapie der akuten bipolaren Erkrankung. Kniffliger Balanceakt zwischen Manie und Depression.
MMW Fortschr Med. 2003; 26:145 Suppl 2:27-30. Review
Grunze H, Dittmann S.


Bipolare Mischzustände – diagnostische und therapeutische Herausforderung.
PPT. 2003; 10:87-93
Severus E, Grunze H.


Pro+ Kontra-Bipolare Störungen-„Valproat ist der Mood Stabilizer der ersten Wahl“.
Info Neurologie& Psychiatrie 2003, 5 (4), 56-57
Grunze H


Antiepileptikum als mögliche option-Sind (Fr)essattacken medikamentös behandelbar?
Info Neurologie& Psychiatrie 2003, 5 (5), 6-7
Grunze H


Bipolare Depressionen- Mit Kombinationstherapie zum Erfolg.
Neurotransmitter 2003, 14 (2), 63-66
Grunze H


Stanley Foundation Bipolar Network. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.
Bipolar Disord. 2003; 5(6):396-406.
Post RM, Leverich GS, Nolen WA, Kupka RW, Altshuler LL, Frye MA, Suppes T, McElroy S, Keck P, Grunze H, Walden J


An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disord. 2003; 5(5):310-9.
Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Keck PE Jr, McElroy SL, Kupka R, Nolen WA, Grunze H, Walden J


Lithium in the acute treatment of bipolar disorders-a stocktaking.
Eur Arch Psychiatry Clin Neurosci. 2003; 253(3):115-9.
Grunze H.


The clinical use of gabapentin in bipolar spectrum disorders.
J Affect Disord. 2003; 75(1):83-91.
Carta MG, Hardoy MC, Hardoy MJ, Grunze H, Carpiniello B.


Möller HJ. The use of atypical antipsychotics in Bipolar Spectrum disorders.
Indian J Psychiatry. 2003; 45(1):10-5
Grunze H


Editorial- What are the Key Issues in Bipolar Disorder?
Clinical approaches in Bipolar Disorder 2003, 2(1), 3
Grunze H


The evolution of antiepileptic drugs for mood stabilization and their main mechanisms of action.
Expert Rev Neurother. 2003; 3(1):107-18
Amann B, Grunze H.


Clinical applications of levothyroxine in refractory mood disorders.
Clinical Approaches in Bipolar Disorders. 2003; 2:49-56
Bauer M, Adli M, Bschor T, Heinz A, Rasgon N, Frye M, Grunze H, Kupka R, Whybrow PC.


WFSBP Task Force on Treatment Guidelines for Bipolar Disorders.
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry. 2003; 4(1):5-13.
Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht RW, Vieta E, Möller HJ;


Response to Letter to the Editor from Sireling, World J Biol Psychiatry (2003), 4, 195. Comment on the WFSBP guidelines for the biological treatment of bipolar disorders, Part II: Treatment of mania. World J Biol Psychiatry 2003, 4(4), 195-196
Grunze H .


Pathophysiologische Erklärungsansätze bipolarer Störungen – was kann uns der Wirkmechanismus von Stimmungsstabilisierern verraten?
Krankenhauspsychiatrie. 2002; 12 suppl 1:7- 12,
Grunze H, Walden J.


Bipolare affektive Störungen- Exakte Diagnose-differenzierte Therapie.
Der Neurologe und Psychiater (DNP) 2002; 1-2: 30-36
Walden J und Grunze H.


Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder.
J Affect Disord. 2002; 72 Suppl 1:15-21.
Grunze H, Walden J.


Psychopharmakotherapie bipolarer affektiver Erkrankungen.
Nervenarzt. 2002; 73(1):4-17
Grunze H, Walden J, Dittmann S, Berger M, Bergmann A, Bräunig P, Dose M, Emrich HM, Gastpar M, Greil W, Krüger S, Möller HJ, Übelhack R.


Akute Manie bei schizoaffektiver Störung. Rascher und andauernder Therapieerfolg mit Risperidon.
Psycho 2002, 28 (8), 410-411
Forsthoff A,Pajonk FG, Grunze H


Editorial-Bipolare Störungen.
psycho 2002, 28 (1/4 Sonderausgabe), 3
Walden J, Grunze H.


Oxcarbazepin in der Behandlung des Alkoholentzugsyndroms.
Neuronews 2002, 1 (10.KW)
Walden J, Schaub G, Schneider K, Grunze H


Medikamentöse Behandlung bipolarer Störungen heute.psycho 2002, 28 (1/4 Sonderausgabe), 24-27Grunze H, Dittmann S., Walden J


Bipolare affektive Störungen (manisch-depressive Erkrankungen).Pharma-aktuell 2002, 3 (2), 15-16Walden J, Grunze H.


Editorial. Psychiatric Networks 2002, 5 (1), 5-7
Grunze H.


The place of antidepressants in the acute treatment of bipolar disorder.
Clinical Approaches in Bipolar Disorders 2002; 1(2):40-46
Grunze H, Möller HJ.


World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Bipolar Disorders.
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry. 2002; 3(3):115-24.
Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht R, Vieta E, Möller HJ;


Interferon alpha (IFNalpha) and psychiatric syndromes: a review.
Prog Neuropsychopharmacol Biol Psychiatry. 2002; 26(4):731-46.
Schäfer M, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Schmidt F, Grunze H, Lieb K.


The use of tiagabine in affective disorders.
Pharmacopsychiatry. 2002; 35(1):33-4
Carta MG, Hardoy MC, Grunze H, Carpiniello B.


Bipolar disorder – the orphan for decades becomes a clinical and health economic challenge for the21st century.
Neuropsychobiology. 2002; 45 Suppl 1:1
Walden J, Grunze H, Normann C.


Clinical relevance and treatment possibilities of bipolar rapid cycling.
Neuropsychobiology. 2002; 45 Suppl 1:20-6.
Grunze H, Amann B, Dittmann S, Walden J.


Klinische Relevanz und Behandlungsmöglichkeiten von Rapid Cycling bei Patienten mit bipolarer affektiver Störung.
Fortschr Neurol Psychiatr. 2001; 69(12):569-80
Amann B, Stampfer R, Schmidt F, Mikhaiel P, Hummel B, Sterr A, Schäfer M, Grunze H.


Bipolare Störungen- Depression ist nicht gleich Depression.
Der Neurologe und Psychiater (DNP) 2001; 6(1): 38-40
Grunze H und Walden J


Therapie der bipolaren Manie.
Nervenheilkunde, 2001, 20 (Suppl. 2): 11-14
Schäfer  M,  Grunze H


Neue Strategien in der Langzeitbehandlung der bipolaren Störung.Nervenheilkunde, 2001, 20 (Suppl. 2): 20-24Amann B, Grunze H


Behandlung affektiver Mischzustände und des „rapid cycling“.Nervenheilkunde, 2001, 20 (Suppl. 2): 39-40Erfurth A, Michael N,  Grunze H, Walden


Editorial- Bipolare affektive Störungen.
Psycho 2001,27 (12), 627
Walden J, Grunze H


Medikamentöse Behandlung bipolarer Störungen heute.
psycho 2001, 27 (12), 663-666
Grunze H, Dittmann S, Walden J


Kombinationstherapien-die Zukunft der Behandlung bipolarer Störungen?
Neurotransmitter 2001,12 (6), 71-73
Grunze H


Schnellübersicht Mood stabilizer- Bewährtes und Experimentelles.
Neurotransmitter 2001, 5, 60-63
Amann B, Grunze H


Switch Risiko minimieren.Neuropsychiatrische Nachrichten 2001,1,12Grunze H


New treatment strategies for acute mania.
Psychiatrica Fennica 2001, 32 (Suppl 1), 23-32
Grunze H, Erfurth A, Walden J.


Diagnosis and treatment of bipolar depression.
Psychiatrica Fennica 2001, 32 (Suppl 1), 33-43
Erfurth A, Michael N, Grunze H,  Walden J.


Treatment of bipolar disorders with antiepileptic drugs as mood stabilizers.
Psychiatrica Fennica 2001, 32, suppl 1,13- 22
Walden J, Erfurth A, Grunze H


Neue Perspektiven in der Akutbehandlung der Manie.
PPT. 2000; 7(2):50-56
Grunze H, Schlösser S, Walden J.


Differentielle Wirksamkeit für Phasenprophylaktika bei bipolaren affektiven Erkrankungen.
Psychiatrie und Dialog 2000,14 (1),3-4
Walden J, Grunze H.


Editorial- Bipolare affektive Störungen.Psycho 2000,10, 465Walden J, Grunze H.


Bipolare affektive Erkrankungen – Neue Entwicklungen in der Akutbehandlung.Neurotransmitter. 2000; 11:64-666

Grunze H.


Status Quo-medikamentöse Behandlung bipolarer Störungen.
Psycho 2000,26, 488-490
Grunze H, Schlösser S. 


Novität versus Tradition.
Neuropsychiatrische Nachrichten 2000,5,17
Möller HJ, Grunze H


Neuroleptika können dysphorische Manien begünstigen.
Neuropsychiatrische Nachrichten 2000,4,18
Grunze H


New perspectives in the acute treatment of bipolar depression.
World J Biol Psychiatry. 2000; 1(3):129-36.
Grunze H, Schlösser S, Walden J.


Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?
Eur Arch Psychiatry Clin Neurosci. 2000; 250(2):57-68.
Möller HJ, Grunze H.


Anticonvulsants in the treatment of aggression in the demented elderly.
Psychiatric Networks. 2000; 3:87-95 (ISSN 11289619)
Amann B, Schösser S, Sterr A, Hummel B, Schäfer M, Padovan CS, Grunze H.


Preface-50 years of lithium treatment of Bipolar Disorder: Taking on new challenges-
Neuropsychobiology 2000,42 suppl 1,1
Walden J, Grunze H